18
nanotimes
Companies
Facts
kruptcy enabled Evident to resolve a lawsuit with California-based Invitrogen Corp. Now, Evident is nearing commercialization of a new product in the field of thermoelectrics that will lead to hiring later this year, CEO Clint Ballinger said to Business Review in Albany. SOLA Ltd., a U.S. hedge fund, owns 73% of Evident.
Adam Sichko: Evident clears bankruptcy court; $75K/ month fed grant in works, In: The Business Review (Albany), April 9, 2010: ht tp: / / a lbany .bi z journa l s . com/ a lbany / s to-
A
ries/2010/04/12/
story6.html?b=1271044800%5E3160151 &ana=e_vert
http://www.evidenttech.com
F
resco Microchip Inc., a fabless semiconductor company focused on leading edge RF, mixed-
signal and digital signal processing integrated circuits (ICs), has shipped more than five million receivers for the global hybrid (analog + digital) television market. The company’s exponential sales ramp demonstrates that Fresco Microchip’s game chan- ging technology, which offers unprecedented picture quality and lower system costs, has transformed the TV receiver industry by delivering value through innovation.
federal judge has cleared Evident Technologies Inc. to emerge from bankruptcy. The ban-
principal analyst at In-Stat. “Hybrid-ready tuners represent over 70% of all TV tuners projected for 2010.”
In January 2010, Fresco announced that the compa- ny had shipped more than one million units. In just two months, shipments have increased five-fold and Fresco anticipates strong growth to continue in next months. Seven of the top nine tuner manufacturers, who account for nearly 70% of all tuners sold today, are in production or designing products using Fresco inside. Fresco has set the de-facto industry standard for superior broadcast quality at the lowest system cost.
The Company closed a financing round totaling $10
million in October 2009. Celtic House Venture Part-
ners and Ventures West led the financing round. Fresco will expand its commercial activities and bring new products to market with the funding.
http://www.frescomicrochip.com
F
luidigm Corporation and SABiosciences (a QIAGEN Company) have teamed up to create
over 100 pathway-focused gene expression panels validated for real-time PCR analysis on the Fluidigm BioMark™ System for Genetic Analysis. These kits are named the RT² Profiler™ PCR Arrays for the Fluidigm BioMark system.
“Fresco’s technology has created a fundamental paradigm shift in the industry and the company is emerging as a top supplier for global hybrid recei- vers, particularly in Europe,” said Gerry Kaufhold,
These gene expression assays are specifically desi- gned for the workflow of Fluidigm‘s integrated fluidic circuits (IFCs) and the BioMark system. Each reagent kit includes pre-aliquoted reagents and primers needed for synthesizing first-strand cDNA ready for preamplification and pathway-focused analysis. PCR Arrays contain enough reagent to run five 96.96
10-04 :: April 2010
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87